µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æ×¨Òµ£º #]^M/y
h
vVsaGW
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ _p9 _P g8
&b2@+/ F
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) vB5mOXGN q
JxM32?Rm*w
1. ICAM-1 2+R]q35-
PMvm4<
2. interleukin 12(IL-12) H
;Gs0Qi;
v^[!NygShs
3. tumor infiltrating lymphocyte HPo><u
Q2Uk0:M
4. TCR/CD3 complex {`Mb ),G
Uf
?+oc'{
5. hematopoietin receptor family eq9qE^[Z&
6QP T
6. individual idiotype(IdI) jDj=a->e^
EFu>
7. integrin X6?Gxf,
t6)R37
8. colony-stimulatory factor (CSF) PX?^v8wlqL
iA'p!l|P
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© Ct3+ga$
-YipPo"a
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? CdtwR0
;BHIss7
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ |I.5]r-EK
(YYwn@NGj
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷ÓᣠItAC=/(d
u (`7F(R
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØÏµ¡£ sq8O+AWl
A=*6|1w;
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) `_J>R
g+C~}M_7
1. ÊÔÊö¸ÉÈÅËØµÄ·ÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌØµã¡£Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËØ¼ì²âµÄ·½·¨ºÍÔÀí¡£ %XXjQ5p
SNH AL F
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) j
?!/#'
gLbTZM4i
3. immunoglobulin superfamily (IgSF) 9a'}j#mJo
OoZv\"}!_
4. selectin :QMpp}G
8%b-.O:_$
5. anti-idiotypic antibody (¦ÁId) A5G@u}YS5
t & 5s.
6. major histocompatibility complex(MHC) &Hl
w2^
+n|@'= ]
7. immunotolerance }&EdA;/o_
*
a VT
8. biological reponse modifier(BRM) 1EliR uJ
O+~@S~
9. immune reponse gene (Ir gene) tz%H1`
,u.A[{@py
10. reshaped antibody (or reconstituted antibody) Acb %)Y
>i2WYT
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© kyD*b3MN
k,r}X:<6jz
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ VS5D)5w#
kg$w<C@#"
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? ,{#L i
?a~#`<
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ PkF'#W%
z*/}rk4i
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? ^
}|$_
stOD5yi
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ 12 bztlv
C)ebZ
3
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? zUJPINDb
Jrx]/CM
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ = /=?l
2S-z$Bi}]
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ _RG2I)P
Xxs0N_va&
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? oMF[<Xf
c.;<+dYsm*
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ @}A3ie'w
-W)8Z.
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: V(6Ql
j7
w;V+)r?w
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: #(r1b'jfP
r%` |kN
̉񧄤 >W=^>8u
:&$WW
v
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 6G?7>M
=~{W;VZt'
1. CD8 Hr;\}
d{RMX<;G
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) Cg%}=
rJc=&'{&)N
3. immunoglobulin fold(Ig fold) hbTJXP~~?
3 bll9Ey
4. cadherin (Ca-dependent cell adhesion moleculers) '=>l& ;
jo[U6t+pj7
5. idiotype-anti-idiotypic antibody immune network theory '8UhYwyr
.jbT+hhM
6. HLA class II antigen ZTK)N
5*r5?n
e
7. complementarity-determining region (CDR) {#}?-X
<+e&E9;>6
8. perforin(or pore-forming protein ,PFP) &W-1W99auE
;F\sMf{
9. high affinity IL-2 receptor ? ]hS^&
>7nOR
10. artificial active immunization >Mk#19j[/
t[b@P<F
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© wVtBH
_>
WO"<s{v
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦Óᣠ?4MZT5 .
2U`g[1
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 2+qU9[kd|
t
gHXIr}3
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ #EX NS r
&=hkB9
;
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ O(YvE
R)BH:wg"
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ 5{O9<~,
+]jJ: V
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? 7DCu#Y[
8VR!
Y0`e
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ 3[}w#n1
Q804_F
F#
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ Q[UYNQ0w
DYaOlT(rE
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ~U`|+
5
l\1_v7s
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ Lt\=E8&rh
} {<L<
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© uT2w2A;
OIdoe0JR:O
1. immunoglobulin gene rearrangement NJ$c0CNy
tboc7Hor4
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) A<<Bm M.%
rWD*DmY@"
3. flow cytometry(FCM) P_Ni
5s)
k#pNk7;MZ
4. carrier effect xr).ZswQ
h$rk]UM/Q
5. positive selection of T lymphocytes in thymus mZ}C)&,m2
Nr:%yvk%s
6. mouse TH1(Th1) and TH2(Th2) subsets e.?;mD
Xwt}WSdF`k
7. perforin (pore-forming protein ,PFP) Q 2nqA1sRk
UJhUb)}^
8. ADCC(antibody-dependent cell-mediated cytotoxicity) 31=vUS
BhCOT+i;c
9. SH-2(src-homology region 2) 2L|)uCb
5;Q9Z1
`
10. Ab2¦Â (internal image) &24$*Oe
J\c\Ar:
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© .rs\%M|X
HA0Rv#p
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? YH/3N(],
R"V^%
z;8o
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? 35PIfqm
,R2;oF_
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦ÓᣠBNpc-O~
L|N[.V9
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ ^U[yk'!Y
8lfKlXR78
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦Óᣠ4NxI:d$&*
.}x:yKyi@
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) )9'Zb`n
*>8Y/3Y\B
ÃâÒßѧרҵ£º fNaboNj[
_ !H8j/b
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£
unN=yeut
x!QA* M
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? G0&'B6I>
Q3|I.I e
´«È¾²¡Ñ§×¨Òµ£º 'ghwc:Og|%
Sxg&73;ZV
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦Äܿɷ¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ :Co+haW
$1bx\
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØÏµ¡£ A!.* eIV|
qbu5aK}+
Ïû»¯×¨Òµ£º /{HK0fd
k*Vf2O3${
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ XX|wle1Kg
#uillSV
2.¼òÊöճĤÏà¹ØÁܰÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌØµã¡£·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? '1te(+;e@
~u+|NtF
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ |cd=7[B
[$P.ek<
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© ;|H(_J=6k
Y%A
KN
1. Fas(CD95)/FasL 95X!{\
*&sXC@^@^
2. common chain of cytokine receptor Imm|5-qJ
J0a#QvX!
3 . TCR/CD3 complex Mh;rhQ
`p{,C`g,R
4. negaive selection of thymocytes j~:N8(=
RFzMah?Q=j
5. artificial active immune kx_PMpc
Qpaan
6. anti-idiotypic jYi{[**
'YUx&FcM
7. IgSF <<:a>)6\
=gb(<`{
>
8. Integrin ":upo/xN
T24?1
9. chemokine *)H&n>"e
OlI {VszR
10. B7/CD28 WCPl}7>
!NfN16
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© qn4jy6
7/$s!pV
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ m;]glAtt
wRi` L7
2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£ SWGD(]}uz
zxr|:KC ?&
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ wWNHZv&
z
nc'
4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£ &@MiR8
*1[v08?!
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ s
s*% 3<
eHjn<@
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ xXktMlI
=NHzh!
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© :z!
N_]t
Evn=3Tw
1. B7/CD28 !awfxH0
.#]
V5g,
2. Th1 subset oVLgH B\zL
=a<};X
3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
BWct0=
. .|>|X4
4. antibody affinity maturation AIvIQ$6}
{i7Wp$ug
5. AP-1 Qw ukhD7
gqje]Zc<
6. single chain variable fragment£¨ScFv£© 7X$[E*kd
DUk&`BSJ
7. NK cell receptor }T?0/N3y&
GN4'LU
8. Zinkernagel-Doherty phenomenon hy"O_Le
_JZwd9K
9. Ig fold +h
}>UK\
2Qqk?;^1
10. CD40/CD40L UvSvgDMl
gNdEPaaFI
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© RnN]m!"5
9y(75Bn9
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£ p`jkyi
2
g elmQnc
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿ B&~#.<23:
[X'XxYbZ
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿ %T hY6y(
b]'Uv8f bF
Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩ Q= DP# 9&
@)A) cBv#
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£ Zl69d4vG
d{cd+An
2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£ 3BuG_ild
Wgx
Gx`Y)
3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£ :a M
ZJm
x;&01@m.
Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ £¨ÃâÒßѧרҵºÍרҵ»ù´¡£© @6eM{3E.
5OUGln5
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© f}JiYZ
D#ZzhHHP
1.Co-stimulators (or co-stimulating molecules) n[~kcF
gnjh=anVX1
2.NK-kB RRW/.y
Aofk< O!M
3.Immunoglobulin superfamily ]JQ7x[
ldd|"[Ds
4.antigen-presenting cell (APC) Tm!pAD
CH!>RRF
5.death domain x=1Iuc;&3
/NFk@8<?
6.CCR and CXCR bXVH7F y
pKe
K6K\8
7.Lectin (or mitogen) C`qo
?T]` X
8.Clusters of differentiation, CD) Q"o* \I
&J>XKO nl
9.B7 family ,8=`Y9#
]q#w97BxiJ
10.Cytotoxic T lymphocyte, CTL) 9|kc$+(+6
8>U{>]WG
11.IL-15 and IL-15 receptor (IL-15R) ORVFp]gG
(T290a9y>
12.MHC restriction R,+Pcn$ws
1!(Og~#(
13.Affinity-chromatography 9%{V?r]k
]2:w?+T
14.Cyctosprin A, CsA 4Ss4jUj
r;>2L'
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) %Aqt0e
+c7e[hz
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© jN3K=
MA
}PC_qQF
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 }s9eRmJs
FfeX;pi
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ yj:<3_-C*
xE$>;30b_
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ y cT@D/
g1!ek
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© V4["+
Y
]'.D@vFGO
ÃâÒßѧרҵ£º =&_Y=>rA]0
.RazjXAY
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ (BT{\|,V_m
B;vpG?s{9
Ïû»¯ÄÚ¿Æ£º 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ xYLTz8g=
9Sb[5_Q
ѪҺ²¡Ñ§×¨Òµ£º 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿ n<
)gS7
)yl;i
Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ (רҵ»ù´¡: ÃâÒßѧ) G?,b51"
?hFG+`"W
Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö) Il
4R R
["u:_2!4P
1. ADCC(antibody dependent cell-mediated cytotoxicity) VYo2m
m=4hi(
g
2. »·æß¾úËØ(cyclosporin) x/d(" Bb
O0Pb"ou_h.
3. KIR(killer cell inhibitory receptor) %a=^T?8
*SmR|Qy
4. HLDA(human leucocyte differentiation antigen) mS9ITe
M
"9v4'"
5. Interleukin 18(IL-18) `9`T,uJe
q; ?Kmk
6. ÕûºÏËØ(integrin) l+r3|b
r.ib"W#4
7. Fas/FasL H/^t]bg,
/D>G4PP<
8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå) ]kir@NMv>
2[X\*"MQ2
9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM) DX(!G a
-}CMNh
10. Th1/Th2 [r0`D^
*=
|@Ze{\
11. »ùÒòÒßÃç(DNAÒßÃç) /=[hRn@)A
gkFw=Cd
12. chemokines and chemokine receptor uwc@~=;
c2Yrg@) [
13. ÃâÒßÄÍÊÜ mO0}Go8
_W
14. ¹²´Ì¼¤·Ö×Ó /2x@Z>
>zV
15. ËÀÍö½á¹¹Óò(death domain) ho%G
0gsRBy
¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö) K)#6&\0tT
6){nu rDBG
1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬? EQVa8xt/C
$Ned1@%[
2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦ÓᣠmCSt.n~
YM&i
£¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î t[p/65L>8
P*/ig0_fM
£¨2£©1977Ä꣺·ÅÉäÃâÒß·¨ :U,-
v
cuh Z_l
£¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå 4l@aga
Q#lFt,.y
£¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹ 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£ ~Z}DN*S
42=/$V
Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ) ÎÊ´ðÌâ(ÿÌâ25·Ö) w"q^8"j!
3/Dis)
v8
1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£ ;~Gez;AhK
^!Tq(t5V
2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿ =kb/4eRg
"4L_BJZ
3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£ 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£